Cephagenix ApS: Financial statements 2021
CVR: 41175486
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Cephagenix ApS (CVR 41175486) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,946,756 and a net result of DKK -1,399,077 compared with DKK -940,614 the year before. Equity in the 2021 report amounted to DKK 1,610,307. The solvency ratio was 61.6%.
- Gross Profit
- DKK -1,946,756
- Profit/Loss
- DKK -1,399,077
- Equity
- DKK 1,610,307
- Total Assets
- DKK 2,615,666
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -1.9M | -1.4M | 1.6M | - |
| 2020 | - | -1.3M | -941K | 259K | - |
Official annual report
Find more companies like Cephagenix ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Cephagenix ApS has published its interim report for the period February 17, 2020 to December 31, 2020.
About Cephagenix ApS
Cephagenix ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ismahane Bali. The company is owned by Cephagenix SAS. According to the 2024 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK -176,320 and a net result of DKK -105,608 compared with DKK -2,474,554 the year before. Equity in the 2024 report amounted to DKK 82,179.